These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 25376228

  • 1. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
    Pang T, Leach ST, Katz T, Jaffe A, Day AS, Ooi CY.
    J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
    [Abstract] [Full Text] [Related]

  • 2. Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10years old.
    Garg M, Leach ST, Pang T, Needham B, Coffey MJ, Katz T, Strachan R, Widger J, Field P, Belessis Y, Chuang S, Day AS, Jaffe A, Ooi CY.
    J Cyst Fibros; 2018 Jan; 17(1):109-113. PubMed ID: 28754328
    [Abstract] [Full Text] [Related]

  • 3. Intestinal inflammation and impact on growth in children with cystic fibrosis.
    Dhaliwal J, Leach S, Katz T, Nahidi L, Pang T, Lee JM, Strachan R, Day AS, Jaffe A, Ooi CY.
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):521-6. PubMed ID: 25539196
    [Abstract] [Full Text] [Related]

  • 4. Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?
    Ooi CY, Pang T, Leach ST, Katz T, Day AS, Jaffe A.
    Dig Dis Sci; 2015 Oct; 60(10):2946-52. PubMed ID: 26271615
    [Abstract] [Full Text] [Related]

  • 5. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
    Chung-Faye G, Hayee B, Maestranzi S, Donaldson N, Forgacs I, Sherwood R.
    Inflamm Bowel Dis; 2007 Nov; 13(11):1374-8. PubMed ID: 17577247
    [Abstract] [Full Text] [Related]

  • 6. Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children.
    Garg M, Leach ST, Coffey MJ, Katz T, Strachan R, Pang T, Needham B, Lui K, Ali F, Day AS, Appleton L, Moeeni V, Jaffe A, Ooi CY.
    J Cyst Fibros; 2017 Sep; 16(5):631-636. PubMed ID: 28416415
    [Abstract] [Full Text] [Related]

  • 7. Evidence for a Cystic Fibrosis Enteropathy.
    Adriaanse MP, van der Sande LJ, van den Neucker AM, Menheere PP, Dompeling E, Buurman WA, Vreugdenhil AC.
    PLoS One; 2015 Sep; 10(10):e0138062. PubMed ID: 26484665
    [Abstract] [Full Text] [Related]

  • 8. Fecal pyruvate kinase is not suitable for discrimination between inflammatory bowel disease exacerbation and acute gastroenteritis.
    Czub E, Nowak JK, Moczko J, Mankowski P, Lisowska A, Banaszkiewicz A, Banasiewicz T, Walkowiak J.
    Dev Period Med; 2015 Sep; 19(2):167-73. PubMed ID: 26384117
    [Abstract] [Full Text] [Related]

  • 9. Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study.
    Shastri YM, Povse N, Schröder O, Stein J.
    Clin Lab; 2008 Sep; 54(9-10):389-90. PubMed ID: 19097497
    [No Abstract] [Full Text] [Related]

  • 10. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis.
    Lisowska A, Madry E, Pogorzelski A, Szydłowski J, Radzikowski A, Walkowiak J.
    Scand J Clin Lab Invest; 2010 Sep; 70(5):322-6. PubMed ID: 20560844
    [Abstract] [Full Text] [Related]

  • 11. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.
    Fallahi G, Motamed F, Yousefi A, Shafieyoun A, Najafi M, Khodadad A, Farhmand F, Ahmadvand A, Rezaei N.
    Turk J Pediatr; 2013 Sep; 55(5):475-8. PubMed ID: 24382526
    [Abstract] [Full Text] [Related]

  • 12. Calprotectin in cystic fibrosis.
    Rumman N, Sultan M, El-Chammas K, Goh V, Salzman N, Quintero D, Werlin S.
    BMC Pediatr; 2014 May 29; 14():133. PubMed ID: 24885444
    [Abstract] [Full Text] [Related]

  • 13. The intestinal virome in children with cystic fibrosis differs from healthy controls.
    Coffey MJ, Low I, Stelzer-Braid S, Wemheuer B, Garg M, Thomas T, Jaffe A, Rawlinson WD, Ooi CY.
    PLoS One; 2020 May 29; 15(5):e0233557. PubMed ID: 32442222
    [Abstract] [Full Text] [Related]

  • 14. Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activity.
    Czub E, Nowak JK, Szaflarska-Poplawska A, Grzybowska-Chlebowczyk U, Landowski P, Moczko J, Adamczak D, Mankowski P, Banasiewicz T, Plawski A, Walkowiak J.
    Acta Biochim Pol; 2014 May 29; 61(1):99-102. PubMed ID: 24649481
    [Abstract] [Full Text] [Related]

  • 15. Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders.
    Jeffery J, Lewis SJ, Ayling RM.
    Inflamm Bowel Dis; 2009 Nov 29; 15(11):1630-4. PubMed ID: 19462434
    [Abstract] [Full Text] [Related]

  • 16. Fecal Calprotectin in Cystic Fibrosis and Its Relation to Disease Parameters: A Longitudinal Analysis for 12 Years.
    Ellemunter H, Engelhardt A, Schüller K, Steinkamp G.
    J Pediatr Gastroenterol Nutr; 2017 Oct 29; 65(4):438-442. PubMed ID: 28207476
    [Abstract] [Full Text] [Related]

  • 17. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.
    Flass T, Tong S, Frank DN, Wagner BD, Robertson CE, Kotter CV, Sokol RJ, Zemanick E, Accurso F, Hoffenberg EJ, Narkewicz MR.
    PLoS One; 2015 Oct 29; 10(2):e0116967. PubMed ID: 25658710
    [Abstract] [Full Text] [Related]

  • 18. Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis.
    Frin AC, Filippi J, Boschetti G, Flourie B, Drai J, Ferrari P, Hebuterne X, Nancey S.
    Dig Liver Dis; 2017 Jan 29; 49(1):11-16. PubMed ID: 27693318
    [Abstract] [Full Text] [Related]

  • 19. Severe disease in Cystic Fibrosis and fecal calprotectin levels.
    Parisi GF, Papale M, Rotolo N, Aloisio D, Tardino L, Scuderi MG, Di Benedetto V, Nenna R, Midulla F, Leonardi S.
    Immunobiology; 2017 Mar 29; 222(3):582-586. PubMed ID: 28012584
    [Abstract] [Full Text] [Related]

  • 20. Comparison of fecal pyruvate kinase isoform M2 and calprotectin in acute diarrhea in hospitalized children.
    Czub E, Nowak JK, Moczko J, Lisowska A, Banaszkiewicz A, Banasiewicz T, Walkowiak J.
    Sci Rep; 2014 Apr 24; 4():4769. PubMed ID: 24759699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.